Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 1
1981 3
1982 1
1983 2
1986 1
1987 3
1988 7
1989 11
1990 4
1991 7
1992 8
1993 9
1994 9
1995 11
1996 10
1997 10
1998 9
1999 13
2000 20
2001 16
2002 19
2003 20
2004 19
2005 29
2006 26
2007 19
2008 22
2009 22
2010 29
2011 22
2012 25
2013 28
2014 36
2015 32
2016 35
2017 55
2018 50
2019 44
2020 48
2021 53
2022 46
2023 44
2024 36

Text availability

Article attribute

Article type

Publication date

Search Results

388 results

Results by year

Filters applied: Meta-Analysis, Review, Systematic Review, in the last 10 years. Clear all
Page 1
Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments.
Maronese CA, Pimentel MA, Li MM, Genovese G, Ortega-Loayza AG, Marzano AV. Maronese CA, et al. Am J Clin Dermatol. 2022 Sep;23(5):615-634. doi: 10.1007/s40257-022-00699-8. Epub 2022 May 24. Am J Clin Dermatol. 2022. PMID: 35606650 Free PMC article. Review.
Low-evidence studies and a lack of validated diagnostic and response criteria have hindered the discovery and validation of new effective treatments for pyoderma gangrenosum. We review established and emerging treatments for pyoderma gangrenosum. ...Fo …
Low-evidence studies and a lack of validated diagnostic and response criteria have hindered the discovery and validation of new effective tr …
Pyoderma gangrenosum.
Maverakis E, Marzano AV, Le ST, Callen JP, Brüggen MC, Guenova E, Dissemond J, Shinkai K, Langan SM. Maverakis E, et al. Nat Rev Dis Primers. 2020 Oct 8;6(1):81. doi: 10.1038/s41572-020-0213-x. Nat Rev Dis Primers. 2020. PMID: 33033263 Review.
Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis that presents with rapidly developing, painful skin ulcers hallmarked by undermined borders and peripheral erythema. ...
Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis that presents with rapidly developing, painful skin ulcers hallmar
Pyoderma Gangrenosum: A Literature Review.
Barbe M, Batra A, Golding S, Hammond O, Higgins JC, O'Connor A, Vlahovic TC. Barbe M, et al. Clin Podiatr Med Surg. 2021 Oct;38(4):577-588. doi: 10.1016/j.cpm.2021.06.002. Clin Podiatr Med Surg. 2021. PMID: 34538436 Review.
Pyoderma gangrenosum (PG), which most frequently affects the lower extremity, is a complicated disease state that results from a combination of inflammation, neutrophilic invasion, and genetic predisposition. ...
Pyoderma gangrenosum (PG), which most frequently affects the lower extremity, is a complicated disease state that results from
Pyoderma Gangrenosum: Treatment Options.
Dissemond J, Marzano AV, Hampton PJ, Ortega-Loayza AG. Dissemond J, et al. Drugs. 2023 Sep;83(14):1255-1267. doi: 10.1007/s40265-023-01931-3. Epub 2023 Aug 23. Drugs. 2023. PMID: 37610614 Free PMC article. Review.
Pyoderma gangrenosum is a rare neutrophilic dermatosis that leads to exceedingly painful ulcerations of the skin. ...
Pyoderma gangrenosum is a rare neutrophilic dermatosis that leads to exceedingly painful ulcerations of the skin. ...
Pyoderma gangrenosum and myeloproliferative neoplasms.
Langabeer SE. Langabeer SE. Clin Exp Dermatol. 2023 Apr 27;48(5):555-556. doi: 10.1093/ced/llad037. Clin Exp Dermatol. 2023. PMID: 36702807 Review.
Pyoderma gangrenosum can be associated with haematological malignancies but rarely a myeloproliferative neoplasm. A review of requests for molecular detection of myeloproliferative neoplasm driver mutations in patients with pyoderma gangrenosum was per
Pyoderma gangrenosum can be associated with haematological malignancies but rarely a myeloproliferative neoplasm. A review of
[Pyoderma gangrenosum].
Burian EA, Karlsmark T, Fogh K, Bech R. Burian EA, et al. Ugeskr Laeger. 2021 Jun 14;183(24):V12200949. Ugeskr Laeger. 2021. PMID: 34120685 Free article. Review. Danish.
Pyoderma gangrenosum is a diagnostic and therapeutic challenge. A misdiagnosis or delayed diagnosis can lead to increased morbidity and death. ...
Pyoderma gangrenosum is a diagnostic and therapeutic challenge. A misdiagnosis or delayed diagnosis can lead to increased morb
Pyoderma gangrenosum.
Mehrtens SH, Crawley JM. Mehrtens SH, et al. Br J Hosp Med (Lond). 2015 Nov;76(11):C173-6. doi: 10.12968/hmed.2015.76.11.C173. Br J Hosp Med (Lond). 2015. PMID: 26551510 Review. No abstract available.
Pyoderma Gangrenosum: An Update on Pathophysiology, Diagnosis and Treatment.
Alavi A, French LE, Davis MD, Brassard A, Kirsner RS. Alavi A, et al. Am J Clin Dermatol. 2017 Jun;18(3):355-372. doi: 10.1007/s40257-017-0251-7. Am J Clin Dermatol. 2017. PMID: 28224502 Review.
Pyoderma gangrenosum (PG) is a rare inflammatory neutrophilic disorder with prototypical clinical presentations. ...
Pyoderma gangrenosum (PG) is a rare inflammatory neutrophilic disorder with prototypical clinical presentations. ...
Pyoderma Gangrenosum: A Challenging Cutaneous Manifestation in Dubowitz Syndrome.
Ghode DB, Hirani S, Kenjale S, Heda A, Hirani S, Prasad R, Wanjari M. Ghode DB, et al. Cureus. 2023 Aug 13;15(8):e43408. doi: 10.7759/cureus.43408. eCollection 2023 Aug. Cureus. 2023. PMID: 37706150 Free PMC article. Review.
Clinical characteristics of Pyoderma gangrenosum in Dubowitz syndrome include painful necrotic ulcers with undermined borders. ...Specific considerations for treating pyoderma gangrenosum in Dubowitz syndrome include collaboration among specialists and …
Clinical characteristics of Pyoderma gangrenosum in Dubowitz syndrome include painful necrotic ulcers with undermined borders. …
Narrative Review: Pyoderma Gangrenosum.
Park AN, Raj A, Bajda J, Gorantla VR. Park AN, et al. Cureus. 2024 Jan 7;16(1):e51805. doi: 10.7759/cureus.51805. eCollection 2024 Jan. Cureus. 2024. PMID: 38187026 Free PMC article. Review.
Pyoderma gangrenosum (PG) is a skin lesion, characteristically a neutrophilic dermatosis, that can be complicated by rapid progression, necrosis, and ulceration. ...
Pyoderma gangrenosum (PG) is a skin lesion, characteristically a neutrophilic dermatosis, that can be complicated by rapid pro
388 results